Apollo Endosurgery Announces Stefanie Cavanaugh as Chief Financial Officer
AUSTIN – March 17, 2015 – Apollo Endosurgery, Inc., a leader in minimally invasive endoscopic surgical products for bariatric and gastrointestinal procedures, today announced that it has appointed Stefanie Cavanaugh as Chief Financial Officer. Cavanaugh brings to Apollo Endosurgery more than 30 years of financial management experience. She will be reporting to Apollo Endosurgery’s Chief Executive Officer, Todd Newton.
“On behalf of Apollo’s Board and Management, I would like to welcome Stefanie as our new CFO,” said Newton. “We are fortunate to have a seasoned professional like Stefanie as part of our team. Stefanie’s broad range of experience makes her an excellent addition to the company and I know she will be an asset for Apollo as we further grow and develop.”
Prior to joining Apollo, Cavanaugh was Senior Vice President of Finance for Harden Healthcare from 2010 until its sale to Gentiva Health Services in 2014. She began her career with Ernst & Young before serving in executive management positions at The Cancer Therapy and Research Center, Encore Medical Corporation, and Solis Women’s Health. Cavanaugh is a CPA and holds a Bachelor of Business Administration (BBA) in Accounting and Finance from the University of Texas, Austin.
About Apollo Endosurgery, Inc.
Apollo Endosurgery, Inc. is a leader in minimally invasive endoscopic surgical products for bariatric and gastrointestinal procedures. Apollo Endosurgery was cofounded with the Apollo Group, a unique collaboration of physicians from the Mayo Clinic, Johns Hopkins University, Medical University of South Carolina, the University of Texas Medical Branch and the Chinese University of Hong Kong. This collaboration developed a broad portfolio of patents in the field of endoscopic surgery that became the foundation of Apollo Endosurgery. For more information regarding Apollo Endosurgery, go to: www.apolloendo.com